SCHEMBL426276

SCHEMBL426276

O=C(O)c1cccc(C(=O)c2cccc(C(=O)c3cccc(C(=O)O)c3C(=O)O)c2)c1C(=O)O

nearest known ligand 0.61

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
AKR1C3 P42330 3/20 0.61
POLB P06746 2/20 0.61
CDC25B P30305 3/20 0.58
CDC25A P30304 1/20 0.58
HSD17B10 Q99714 1/20 0.58
ATM Q13315 2/20 0.54
TDP1 Q9NUW8 1/20 0.54
L3MBTL1 Q9Y468 1/20 0.54
ALDH1A1 P00352 3/20 0.51
MYC P01106 1/20 0.49
MEN1 O00255 1/20 0.47
PKM P14618 1/20 0.47
KMT2A Q03164 1/20 0.47
NR4A1 P22736 1/20 0.47
KDM4E B2RXH2 1/20 0.47
ALOX15 P16050 1/20 0.44
LMNA P02545 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30978151 0.90 AKR1C3 (0.76) AKR1C3POLBCDC25BCDC25AHSD17B10
SCHEMBL144047 0.90 AKR1C3 (0.76) AKR1C3POLBCDC25BCDC25AHSD17B10
SCHEMBL2435586 0.89 KDM4E (0.58) AKR1C3POLBCDC25BCDC25AHSD17B10
Hydrochloric Acid SCHEMBL10626938 0.88 AKR1C3 (0.73) AKR1C3POLBCDC25BCDC25AHSD17B10
SCHEMBL425272 0.88 AKR1C3 (0.65) AKR1C3POLBCDC25BCDC25AHSD17B10
SCHEMBL27339882 0.88 AKR1C3 (0.79) AKR1C3POLBCDC25BCDC25AHSD17B10
SCHEMBL64990 0.87 CDC25B (0.79) AKR1C3POLBCDC25BCDC25AHSD17B10
SCHEMBL28067120 0.85 ALDH1A1 (0.50) AKR1C3POLBCDC25BCDC25AHSD17B10
SCHEMBL147496 0.85 CDC25B (0.55) AKR1C3POLBCDC25BCDC25AHSD17B10
SCHEMBL29882813 0.85 CDC25B (0.55) AKR1C3POLBCDC25BCDC25AHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110431696-B Binder composition for secondary battery 日本电气株式会社 2022-12-06 CN disclosed
CN-109563282-B Medical film and method for producing same, medical coating composition, medical device and method for producing same 三井化学株式会社 2022-04-15 CN disclosed
US-11198280-B2 Medical film and method for producing same, medical coating composition, medical device and method for producing same MITSUI CHEMICALS, INC. (JP) 2021-12-14 US disclosed
US-11018341-B2 Binder composition for secondary battery NEC CORPORATION (JP) 2021-05-25 US disclosed
US-10707491-B2 Binder for secondary battery NEC CORPORATION (JP) 2020-07-07 US disclosed
US-20200129377-A1 MEDICAL FILM AND METHOD FOR PRODUCING SAME, MEDICAL COATING COMPOSITION, MEDICAL DEVICE AND METHOD FOR PRODUCING SAME MITSUI CHEMICALS, INC. (JP) 2020-04-30 US disclosed
US-10351673-B2 Block polyimide, block polyamide acid imide and use thereof MITSUI CHEMICALS, INC. (JP) 2019-07-16 US disclosed
EP-3489285-A1 MEDICAL FILM AND METHOD FOR PRODUCING SAME, MEDICAL COATING COMPOSITION, MEDICAL DEVICE AND METHOD FOR PRODUCING SAME Mitsui Chemicals, Inc. (JP) 2019-05-29 EP disclosed
US-20190044149-A1 BINDER FOR SECONDARY BATTERY NEC CORPORATION (JP) 2019-02-07 US disclosed
US-20180226677-A1 MIXTURE PASTE FOR NEGATIVE ELECTRODE OF LITHIUM ION SECONDARY BATTERY, NEGATIVE ELECTRODE FOR LITHIUM ION SECONDARY BATTERY, METHOD FOR PRODUCING NEGATIVE ELECTRODE FOR LITHIUM ION SECONDARY BATTERY, AND LITHIUM ION SECONDARY BATTERY MITSUI CHEMICALS, INC. (JP) 2018-08-09 US disclosed
US-20160053135-A1 POLYAMIC ACID, VARNISH CONTAINING SAME, AND POLYIMIDE FILM MITSUI CHEMICAL, INC. (JP) 2016-02-25 US disclosed
US-20160032055-A1 POLYAMIC ACID, VARNISH COMPRISING SAME AND POLYIMIDE FILM MITSUI CHEMICALS., INC. (JP) 2016-02-04 US disclosed
US-20120021234-A1 LOW-THERMAL-EXPANSION BLOCK POLYIMIDE, PRECURSOR THEREOF, AND USE THEREOF MITSUI CHEMICALS, INC. (JP) 2012-01-26 US disclosed
US-20110318588-A1 POLYAMIC ACID AND POLYIMIDE, PROCESSES FOR THE PRODUCTION OF SAME, COMPOSITONS CONTAINING SAME, AND USES THEREOF Mitsu Chemicals Inc, (TK) 2011-12-29 US disclosed
US-20100304160-A1 POLYIMIDE COMPOSITE MATERIAL AND FILM THEREOF MITSUI CHEMICALS, INC. (JP) 2010-12-02 US disclosed
EP-2218754-A1 POLYIMIDE COMPOSITE MATERIAL AND FILM OF THE SAME Mitsui Chemicals, Inc. (JP) 2010-08-18 EP disclosed
EP-1225192-B1 POLYIMIDES AND POLYAMIC ACIDS MITSUI CHEMICALS INC (JP) 2004-09-22 EP disclosed
US-6599675-B2 Useful for application of photoresist, as an insulation film; heat resistance, mechanical properties and adhesion property MITSUI CHEMICALS, INC. (JP) 2003-07-29 US disclosed
US-20020182536-A1 Polyimides and polyamic acids MITSUI CHEMICALS, INC. (JP) 2002-12-05 US disclosed
EP-1225192-A1 POLYIMIDES AND POLYAMIC ACIDS Mitsui Chemicals, Inc. (JP) 2002-07-24 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110318588-A1 POLYAMIC ACID AND POLYIMIDE, PROCESSES FOR THE PRODUCTION OF SAME, COMPOSITONS CONTAINING SAME, AND USES THEREOF ASS1, TAF1, CPSF1 AKR1C3 2274/4885POLB 1605/4885CDC25B 3675/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.